Abstract
Aim:
Krüppel-like factor 8 (KLF8) plays important roles in cell cycle and oncogenic transformation. On other hand, androgen receptor (AR) is crucial in development of both androgen-dependent and independent prostatic malignancies. The aim of this study is to investigate the role of KLF8 in prostate cancer (PCa) and the relationship between KLF8 and AR.
Methods:
Eight human PCa cell lines, including androgen-dependent LNCap cells and androgen-independent 22Rv1 cells, as well as human PCa samples were studied. LNCap cells and 22Rv1 cells were transfected with plasmids encoding full-length wild-type KLF8 or KLF8 shRNA. The expression of KLF8 protein was detected using Western blotting or immunohistochemical staining. Cell proliferation in vitro was measured with MTT assay, and in vivo in a xenograft nude mouse model. Yeast two-hybrid screening, co-immunoprecipitation and pull down assays were used to examine the binding of KLF8 to AR. Luciferase reporter gene assay was used to measure the transcriptional activity of the genes targeted by AR.
Results:
In 133 human PCa samples, KLF8 protein staining was observed in 92.65% (63/68) of high-grade PCa, 66.15% (43/65) of low-grade PCa, and 6.82% (3/44) of adjacent normal tissues. The expression of KLF8 was significantly associated with poorer overall survival. Overexpression of KLF8 enhanced the proliferation of both LNCap and 22Rv1 cells, while knockdown of endogenous KLF8 suppressed the proliferation. These manipulations exerted similar effects on the tumor volumes in the xenograft nude mouse model. Yeast two-hybrid screening revealed that KLF8 was a novel AR-interacting protein. With pull down assay and co-immunoprecipitation assay, we demonstrated that KLF8 bound directly to AR, and KLF8 enhanced AR target gene transcription.
Conclusion:
The results demonstrate that KLF8 is a novel AR transcriptional co-activator that is overexpressed in PCa and may play a role in progression of hormone-refractory PCa.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics. Cancer J Clin 2006; 56: 106–30.
Cheng H, Snoek R, Ghaidi F, Cox ME, Rennie PS . Short hairpin RNA knockdown of the androgen receptor attenuates ligand-independent activation and delays tumor progression. Cancer Res 2006; 66: 10613–20.
Galbraith SM, Duchesne GM . Androgens and prostate cancer: biology, pathology and hormonal therapy. Eur J Cancer 1997; 33: 545–54.
Liao X, Tang S, Thrasher JB, Griebling TL, Li B . Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer. Mol Cancer Ther 2005; 4: 505–15.
Trapman J, Brinkmann AO . The androgen receptor in prostate cancer. Pathol Res Pract 1996; 192: 752–60.
Claessens F, Verrijdt G, Schoenmakers E, Haelens A, Peeters B, Verhoeven G, et al. Selective DNA binding by the androgen receptor as a mechanism for hormone-specific gene regulation. J Steroid Biochem Mol Biol 2001; 76: 23–30.
Gelmann EP . Molecular biology of the androgen receptor. J Clin Oncol 2002; 20: 3001–15.
Heemers HV, Tindall DJ . Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex. Endocr Rev 2007; 28: 778–808.
Heinlein CA, Chang C . Androgen receptor (AR) coregulators: an overview. Endocr Rev 2002; 23: 175–200.
Feldman BJ, Feldman D . The development of androgen-independent prostate cancer. Nat Rev 2001; 1: 34–45.
Nieto M, Finn S, Loda M, Hahn WC . Prostate cancer: re-focusing on androgen receptor signaling. Int J Biochem Cell Biol 2007; 39: 1562–8.
Pearson R, Fleetwood J, Eaton S, Crossley M, Bao S . Krüppel-like transcription factors: a functional family. Int J Biochem Cell Biol 2008; 40: 1996–2001.
Zhao J, Bian ZC, Yee K, Chen BP, Chien S, Guan JL . Identification of transcription factor KLF8 as a downstream target of focal adhesion kinase in its regulation of cyclin D1 and cell cycle progression. Mol Cell 2003; 11: 1503–15.
Wang X, Zhao J . KLF8 transcription factor participates in oncogenic transformation. Oncogene 2007; 26: 456–61.
Wang X, Urvalek AM, Liu J, Zhao J . Activation of KLF8 transcription by focal adhesion kinase in human ovarian epithelial and cancer cells. J Biol Chem 2008; 283: 13934–42.
Li JC, Yang XR, Sun HX, Xu Y, Zhou J, Qiu SJ, et al. Up-regulation of Krüppel-like factor 8 promotes tumor invasion and indicates poor prognosis for hepatocellular carcinoma. Gastroenterology 2010; 139: 2146–57.
Wang X, Zheng M, Liu G, Xia W, McKeown-Longo PJ, Hung MC, et al. Krüppel-like factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion. Cancer Res 2007; 67: 7184–93.
Debes JD, Tindall DJ . Mechanisms of androgen-refractory prostate cancer. N Engl J Med 2004; 351: 1488–90.
Lamont KR, Tindall DJ . Minireview: alternative activation pathways for the androgen receptor in prostate cancer. Mol Endocrinol 2011; 25: 897–907.
Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M . Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 2000; 103: 843–52.
Kang Z, Pirskanen A, Janne OA, Palvimo JJ . Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex. J Biol Chem 2002; 277: 48366–71.
Linja MJ, Savinainen KJ, Saramaki OR, Tammela TL, Vessella RL, Visakorpi T . Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer. Cancer Res 2001; 61: 3550–5.
Chen CD, Welsbie DS, Tran C, Baek SH, Chen R, Vessella R, et al. Molecular determinants of resistance to antiandrogen therapy. Nat Med 2004; 10: 33–9.
Mohler JL, Gregory CW, Ford OH 3rd, Kim D, Weaver CM, Petrusz P, et al. The androgen axis in recurrent prostate cancer. Clin Cancer Res 2004; 10: 440–8.
Taplin ME, Balk SP . Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence. J Cell Biochem 2004; 91: 483–90.
Chmelar R, Buchanan G, Need EF, Tilley W, Greenberg NM . Androgen receptor coregulators and their involvement in the development and progression of prostate cancer. Int J Cancer 2007; 120: 719–33.
Van Vliet J, Turner J, Crossley M . Human Kruppel-like factor 8: a CACCC-box binding protein that associates with CtBp and represses transcription. Nucleic Acids Res 2000; 28: 1955–62.
Urvalek AM, Wang X, Lu H, Zhao J . KLF8 recruits the p300 and PCAF co-activators to its amino terminal activation domain to activate transcription. Cell Cycle 2010; 9: 601–11.
Wang J, Place RF, Huang V, Wang X, Noonan EJ, Magyar CE, et al. Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration. Cancer Res 2010; 70: 10182–91.
Wei D, Gong W, Kanai M, Schlunk C, Wang L, Yao JC, et al. Drastic down-regulation of Kruppel-like factor 4 expression is critical in human gastric cancer development and progression. Cancer Res 2005; 65: 2746–54.
Yori JL, Seachrist DD, Johnson E, Lozada KL, Abdul-karim FW, Chodosh LA, et al. Kruppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer. Neoplasia 2011; 13: 601–10.
Acknowledgements
This study was supported by the Heilongjiang Province Health Department Fund (No 2010-135).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
He, Hj., Gu, Xf., Xu, Wh. et al. Krüppel-like factor 8 is a novel androgen receptor co-activator in human prostate cancer. Acta Pharmacol Sin 34, 282–288 (2013). https://doi.org/10.1038/aps.2012.130
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/aps.2012.130
Keywords
This article is cited by
-
Role of Krüppel-like factors in cancer stem cells
Journal of Physiology and Biochemistry (2015)
